PL3886908T3 - Preparat zawierający dyspersję fosfolipidów i soli kwasów tłuszczowych - Google Patents

Preparat zawierający dyspersję fosfolipidów i soli kwasów tłuszczowych

Info

Publication number
PL3886908T3
PL3886908T3 PL19836474.7T PL19836474T PL3886908T3 PL 3886908 T3 PL3886908 T3 PL 3886908T3 PL 19836474 T PL19836474 T PL 19836474T PL 3886908 T3 PL3886908 T3 PL 3886908T3
Authority
PL
Poland
Prior art keywords
phospholipids
dispersion
preparation
fatty acid
acid salts
Prior art date
Application number
PL19836474.7T
Other languages
English (en)
Inventor
Martin Schilling
Mario Gomez
Bodo SPECKMANN
Anne BENEDIKT
Christian Kessler
Norbert Windhab
Ines Ochrombel
Original Assignee
Evonik Operations Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Operations Gmbh filed Critical Evonik Operations Gmbh
Publication of PL3886908T3 publication Critical patent/PL3886908T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/105Aliphatic or alicyclic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03Organic compounds
    • A23L29/035Organic compounds containing oxygen as heteroatom
    • A23L29/04Fatty acids or derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277Preparation processes; Proliposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/36Lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL19836474.7T 2018-11-30 2019-11-28 Preparat zawierający dyspersję fosfolipidów i soli kwasów tłuszczowych PL3886908T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18209472 2018-11-30
PCT/EP2019/082919 WO2020109472A1 (en) 2018-11-30 2019-11-28 Preparation comprising a dispersion of phospholipids and fatty acid salts

Publications (1)

Publication Number Publication Date
PL3886908T3 true PL3886908T3 (pl) 2025-09-29

Family

ID=64564653

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19836474.7T PL3886908T3 (pl) 2018-11-30 2019-11-28 Preparat zawierający dyspersję fosfolipidów i soli kwasów tłuszczowych

Country Status (13)

Country Link
US (1) US12194012B2 (pl)
EP (1) EP3886908B1 (pl)
JP (1) JP7438216B2 (pl)
KR (1) KR20210097153A (pl)
CN (1) CN113164611B (pl)
AU (1) AU2019386289B2 (pl)
BR (1) BR112021010240A2 (pl)
CA (1) CA3121055C (pl)
DK (1) DK3886908T3 (pl)
ES (1) ES3038235T3 (pl)
MX (1) MX2021006263A (pl)
PL (1) PL3886908T3 (pl)
WO (1) WO2020109472A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102405390B1 (ko) 2016-07-13 2022-06-03 에보닉 오퍼레이션스 게엠베하 용해된 지질을 함유하는 바이오매스로부터 지질을 분리하는 방법
DK3562925T3 (da) 2016-12-27 2021-05-25 Evonik Operations Gmbh Fremgangsmåde til isolering af lipider fra en lipidholdig biomasse
CA3072846A1 (en) 2017-08-17 2019-02-21 Evonik Operations Gmbh Enhanced production of lipids by limitation of at least two limiting nutrient sources
EP3470502A1 (en) 2017-10-13 2019-04-17 Evonik Degussa GmbH Method of separating lipids from a lysed lipids containing biomass
EP3527664A1 (en) 2018-02-15 2019-08-21 Evonik Degussa GmbH Method of isolating lipids from a lipids containing biomass
CN112166176B (zh) 2018-05-15 2024-06-25 赢创运营有限公司 借助疏水性二氧化硅从含有脂质的生物质中分离脂质的方法
BR112020023222A2 (pt) 2018-05-15 2021-03-23 Evonik Operations Gmbh método de isolamento de lipídios a partir de uma biomassa contendo lipídios lisados por inversão por emulsão
WO2023080712A1 (ko) * 2021-11-05 2023-05-11 ㈜아이엠디팜 신규한 서방성 지질 전구 제제 및 이를 포함하는 서방성 주사용 약학 조성물
WO2025098952A1 (en) * 2023-11-07 2025-05-15 Evonik Operations Gmbh Nutrient preloading of cells

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616594C2 (de) * 1986-05-16 1994-07-28 Kampffmeyer Muehlen Backmittel für Brötchenteige
US5015483A (en) * 1989-02-09 1991-05-14 Nabisco Brands, Inc. Liposome composition for the stabilization of oxidizable substances
JPH06157294A (ja) * 1992-11-19 1994-06-03 Tanabe Seiyaku Co Ltd 脂肪微粒子製剤
JPH06183954A (ja) * 1992-12-24 1994-07-05 Kyowa Hakko Kogyo Co Ltd リポソーム製剤
IT1264987B1 (it) 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
US20070042008A1 (en) * 2005-08-18 2007-02-22 Bodybio, Inc. Compositions containing phosphatidylcholine and essential fatty acids
PT2144618E (pt) * 2007-03-28 2013-07-08 Aker Biomarine Asa Composições bioeficazes de óleo de krill
ES2979118T3 (es) 2009-03-09 2024-09-24 Basf As Composiciones que comprenden una mezcla de aceites de ácidos grasos y un ácido graso libre, y procedimientos y usos de las mismas
WO2011137160A2 (en) 2010-04-30 2011-11-03 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans
US10798962B2 (en) * 2014-12-23 2020-10-13 Evonik Operations Gmbh Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids
WO2016149386A1 (en) * 2015-03-16 2016-09-22 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Biomarkers for malaria diagnosis
WO2017155386A1 (en) 2016-03-08 2017-09-14 N.V. Nutricia Method for treating brain atrophy

Also Published As

Publication number Publication date
AU2019386289B2 (en) 2025-04-24
MX2021006263A (es) 2021-07-06
BR112021010240A2 (pt) 2021-08-17
CA3121055A1 (en) 2020-06-04
JP7438216B2 (ja) 2024-02-26
US12194012B2 (en) 2025-01-14
CN113164611B (zh) 2024-06-25
JP2022509814A (ja) 2022-01-24
KR20210097153A (ko) 2021-08-06
CA3121055C (en) 2024-04-16
WO2020109472A1 (en) 2020-06-04
ES3038235T3 (en) 2025-10-10
CN113164611A (zh) 2021-07-23
EP3886908B1 (en) 2025-06-04
EP3886908A1 (en) 2021-10-06
US20220016065A1 (en) 2022-01-20
AU2019386289A1 (en) 2021-07-15
DK3886908T3 (da) 2025-08-25

Similar Documents

Publication Publication Date Title
PL3886908T3 (pl) Preparat zawierający dyspersję fosfolipidów i soli kwasów tłuszczowych
IL291055A (en) Stable formulations of lipids and liposomes
IL283480A (en) Solid forms of lometaferon and lometaferon salts and processes for preparing lometaferon
EP3821720A4 (en) Microencapsulated conjugated linoleic acid glyceride powder and preparation method thereof
IL261989A (en) A pharmaceutical preparation of flavociclib and a method for its preparation
IL277683A (en) Mono-salts of 6-aminoquinoline and their uses
EP3259483A4 (en) Furniture parts comprising a male part and a female part of a joint
IL234104A0 (en) A method for the preparation of triglycerides of medium chain fatty acids
IL247529B (en) Preparations of choline ester lipoic acid and methods of use
SG11202009315WA (en) Formulation and method of preparation
SG11201803022TA (en) Compositions comprising fatty acids and their use
EP3852544A4 (en) COMPOSITIONS AND METHODS FOR INTRODUCING ODD-CHAIN FATTY ACIDS INTO POULTRY EGGS
EP3318261A4 (en) Use of zoledronic acid to prepare drug treating fatty liver disease
ZA202103212B (en) Composition comprising a choline salt of a fatty acid and its use as a fungicide
PL3463310T3 (pl) Tabletki o wysokiej zawartości składników aktywnych soli aminokwasowych kwasów tłuszczowych omega-3
EP3307250A4 (en) Glycopyrronium fatty acid salts and methods of making same
GB2561121B (en) Branched acid emulsifier compositions and methods of use
GB201717564D0 (en) Universal adpater for a plug connector head and plug connector part having a plug connector head of this kind
IL324298A (en) Using nor-ursodeoxycholic acid to reduce liver fat
PL3471702T3 (pl) Stabilne formulacje z lipidami bakteriobójczymi
HUE045829T2 (hu) Lényegében transz-zsírsavaktól mentes ehetõ emulzió
PL3331497T3 (pl) Preparat nawilżający pochodnej karbamoiloetylowej katiry i sposób jego wytwarzania
AU2019385698B2 (en) Composition comprising a choline salt of a fatty acid and its use as a fungicide
HK1260612A1 (en) Treatments of accumulated fat with deoxycholic acid and salts thereof
HK1228199A1 (en) Lipoic acid choline ester compositions and methods of use